Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
_
_  
Search: 
 
_
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Severe Acute Respiratory Syndrome (SARS)

Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 3

Supplement E: Managing International Travel-Related Transmission Risk

Summary
May 3, 2005

Download PDF version formatted for print Adobe Acrobat Reader (55 KB/1 page)
Download Word version formatted for print Microsoft Word (234 KB/1 page)

Goals

  • Prevent the introduction of SARS-CoV (and spread from an introduction) into the United States from SARS-affected areas.
  • Prevent exportation of SARS-CoV from the United States if domestic transmission presents an increased risk of exportation.
  • Reduce the risk of SARS-CoV disease among outbound travelers to SARS-affected areas.
  • Prevent the transmission of SARS-CoV to passengers on a conveyance with a SARS patient, and evaluate and monitor other passengers to detect SARS-like illness and prevent further spread.
Key concepts
  • SARS-CoV can spread rapidly on a global scale through international travel if control measures are not implemented.
  • SARS-CoV transmission usually involves close contact and is often limited to healthcare settings or households; the risk of SARS to travelers visiting an affected area is low unless travelers are exposed to these settings.
  • Travelers visiting SARS-affected areas can reduce their risk by following recommended guidelines and can help prevent transmission by monitoring their health during and for 10 days after travel.
  • SARS patients can transmit SARS-CoV to other passengers on conveyances and should postpone travel until they are no longer infectious.
  • Active follow-up of passengers on conveyances with SARS cases can help prevent further spread by informing passengers of their exposure and providing instructions for monitoring health and seeking medical evaluation if symptoms develop.
  • Transmission of SARS-CoV on conveyances can occur only if an undetected case boards. Therefore, the primary preventive strategy is to prevent symptomatic persons from traveling.
Priority activities
  • Screen incoming travelers from SARS-affected areas for SARS, and provide guidance about monitoring their health and reporting illness.
  • Provide guidance to outbound travelers about active SARS-affected areas and measures to reduce the risk of acquiring SARS-CoV disease during travel.
  • If SARS-CoV transmission in the United States presents an increased risk of exporting SARS-CoV to other countries, then screen outbound travelers to prevent such exportation.
  • Ensure the appropriate evaluation and management of SARS cases and potentially exposed passengers and crew members on conveyances.

 

_
_
Topic Contents
_ arrow SARS Home
  arrow Community Containment
  arrow Evaluation/Diagnosis
  arrow Exposure Management
  arrow Infection Control
  arrow Laboratory
  arrow Legal Authorities
  arrow Preparedness Planning
  arrow References & Resources
  arrow Surveillance & Reporting
  arrow Travel
  arrow What Everyone Should Know
  arrow What's New
_
_
blackdots
_

Contact Info

Public:
English 800-CDC-INFO
Español 888-246-2857
TTY 888-232-6348
Clinician:
English 877-554-4625
_
arrow Sign up for the Clinician Registry
arrow Contact Us
_
blackdots
_
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USAGovDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (800) CDC-INFO